NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
Clinical trial NCT07261241 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07261241
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2030-07-31
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.